Analysis | Samples | Factors | Units |
---|---|---|---|
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE003 | Treatment:ctrl RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE012 | Treatment:ctrl RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE021 | Treatment:ctrl RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE030 | Treatment:ctrl RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE039 | Treatment:ctrl RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG003 | Treatment:ctrl RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG012 | Treatment:ctrl RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG021 | Treatment:ctrl RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG030 | Treatment:ctrl RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG039 | Treatment:ctrl RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI003 | Treatment:ctrl RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI012 | Treatment:ctrl RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI021 | Treatment:ctrl RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI030 | Treatment:ctrl RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI039 | Treatment:ctrl RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS003 | Treatment:ctrl RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS012 | Treatment:ctrl RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS021 | Treatment:ctrl RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS030 | Treatment:ctrl RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS039 | Treatment:ctrl RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC003 | Treatment:ctrl RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC012 | Treatment:ctrl RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC021 | Treatment:ctrl RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC030 | Treatment:ctrl RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC039 | Treatment:ctrl RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE001 | Treatment:ctrl RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE010 | Treatment:ctrl RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE019 | Treatment:ctrl RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE028 | Treatment:ctrl RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE037 | Treatment:ctrl RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG001 | Treatment:ctrl RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG010 | Treatment:ctrl RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG019 | Treatment:ctrl RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG028 | Treatment:ctrl RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG037 | Treatment:ctrl RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI001 | Treatment:ctrl RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI010 | Treatment:ctrl RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI019 | Treatment:ctrl RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI028 | Treatment:ctrl RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI037 | Treatment:ctrl RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS001 | Treatment:ctrl RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS010 | Treatment:ctrl RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS019 | Treatment:ctrl RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS028 | Treatment:ctrl RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS037 | Treatment:ctrl RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC001 | Treatment:ctrl RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC010 | Treatment:ctrl RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC019 | Treatment:ctrl RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC028 | Treatment:ctrl RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC037 | Treatment:ctrl RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE002 | Treatment:ctrl RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE011 | Treatment:ctrl RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE020 | Treatment:ctrl RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE029 | Treatment:ctrl RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE038 | Treatment:ctrl RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG002 | Treatment:ctrl RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG011 | Treatment:ctrl RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG020 | Treatment:ctrl RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG029 | Treatment:ctrl RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG038 | Treatment:ctrl RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI002 | Treatment:ctrl RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI011 | Treatment:ctrl RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI020 | Treatment:ctrl RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI029 | Treatment:ctrl RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI038 | Treatment:ctrl RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS002 | Treatment:ctrl RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS011 | Treatment:ctrl RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS020 | Treatment:ctrl RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS029 | Treatment:ctrl RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS038 | Treatment:ctrl RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC002 | Treatment:ctrl RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC011 | Treatment:ctrl RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC020 | Treatment:ctrl RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC029 | Treatment:ctrl RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC038 | Treatment:ctrl RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE009 | Treatment:ncl-1 RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE018 | Treatment:ncl-1 RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE027 | Treatment:ncl-1 RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE036 | Treatment:ncl-1 RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE045 | Treatment:ncl-1 RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG009 | Treatment:ncl-1 RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG018 | Treatment:ncl-1 RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG027 | Treatment:ncl-1 RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG036 | Treatment:ncl-1 RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG045 | Treatment:ncl-1 RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI009 | Treatment:ncl-1 RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI018 | Treatment:ncl-1 RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI027 | Treatment:ncl-1 RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI036 | Treatment:ncl-1 RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI045 | Treatment:ncl-1 RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS009 | Treatment:ncl-1 RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS018 | Treatment:ncl-1 RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS027 | Treatment:ncl-1 RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS036 | Treatment:ncl-1 RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS045 | Treatment:ncl-1 RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC009 | Treatment:ncl-1 RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC018 | Treatment:ncl-1 RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC027 | Treatment:ncl-1 RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC036 | Treatment:ncl-1 RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC045 | Treatment:ncl-1 RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE007 | Treatment:ncl-1 RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE016 | Treatment:ncl-1 RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE025 | Treatment:ncl-1 RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE034 | Treatment:ncl-1 RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE043 | Treatment:ncl-1 RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG007 | Treatment:ncl-1 RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG016 | Treatment:ncl-1 RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG025 | Treatment:ncl-1 RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG034 | Treatment:ncl-1 RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG043 | Treatment:ncl-1 RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI007 | Treatment:ncl-1 RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI016 | Treatment:ncl-1 RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI025 | Treatment:ncl-1 RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI034 | Treatment:ncl-1 RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI043 | Treatment:ncl-1 RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS007 | Treatment:ncl-1 RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS016 | Treatment:ncl-1 RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS025 | Treatment:ncl-1 RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS034 | Treatment:ncl-1 RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS043 | Treatment:ncl-1 RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC007 | Treatment:ncl-1 RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC016 | Treatment:ncl-1 RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC025 | Treatment:ncl-1 RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC034 | Treatment:ncl-1 RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC043 | Treatment:ncl-1 RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE008 | Treatment:ncl-1 RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE017 | Treatment:ncl-1 RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE026 | Treatment:ncl-1 RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE035 | Treatment:ncl-1 RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE044 | Treatment:ncl-1 RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG008 | Treatment:ncl-1 RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG017 | Treatment:ncl-1 RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG026 | Treatment:ncl-1 RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG035 | Treatment:ncl-1 RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG044 | Treatment:ncl-1 RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI008 | Treatment:ncl-1 RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI017 | Treatment:ncl-1 RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI026 | Treatment:ncl-1 RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI035 | Treatment:ncl-1 RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI044 | Treatment:ncl-1 RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS008 | Treatment:ncl-1 RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS017 | Treatment:ncl-1 RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS026 | Treatment:ncl-1 RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS035 | Treatment:ncl-1 RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS044 | Treatment:ncl-1 RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC008 | Treatment:ncl-1 RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC017 | Treatment:ncl-1 RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC026 | Treatment:ncl-1 RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC035 | Treatment:ncl-1 RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC044 | Treatment:ncl-1 RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE006 | Treatment:tif-IA RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE015 | Treatment:tif-IA RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE024 | Treatment:tif-IA RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE033 | Treatment:tif-IA RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE042 | Treatment:tif-IA RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG006 | Treatment:tif-IA RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG015 | Treatment:tif-IA RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG024 | Treatment:tif-IA RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG033 | Treatment:tif-IA RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG042 | Treatment:tif-IA RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI006 | Treatment:tif-IA RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI015 | Treatment:tif-IA RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI024 | Treatment:tif-IA RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI033 | Treatment:tif-IA RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI042 | Treatment:tif-IA RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS006 | Treatment:tif-IA RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS015 | Treatment:tif-IA RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS024 | Treatment:tif-IA RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS033 | Treatment:tif-IA RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS042 | Treatment:tif-IA RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC015 | Treatment:tif-IA RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC024 | Treatment:tif-IA RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC033 | Treatment:tif-IA RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC042 | Treatment:tif-IA RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phsophoPC006 | Treatment:tif-IA RNAi | Days of adulthood:12 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE004 | Treatment:tif-IA RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE013 | Treatment:tif-IA RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE022 | Treatment:tif-IA RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE031 | Treatment:tif-IA RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE040 | Treatment:tif-IA RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG004 | Treatment:tif-IA RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG013 | Treatment:tif-IA RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG022 | Treatment:tif-IA RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG031 | Treatment:tif-IA RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG040 | Treatment:tif-IA RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI004 | Treatment:tif-IA RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI013 | Treatment:tif-IA RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI022 | Treatment:tif-IA RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI031 | Treatment:tif-IA RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI040 | Treatment:tif-IA RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS004 | Treatment:tif-IA RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS013 | Treatment:tif-IA RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS022 | Treatment:tif-IA RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS031 | Treatment:tif-IA RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS040 | Treatment:tif-IA RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC013 | Treatment:tif-IA RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC022 | Treatment:tif-IA RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC031 | Treatment:tif-IA RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC040 | Treatment:tif-IA RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phsophoPC004 | Treatment:tif-IA RNAi | Days of adulthood:2 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE005 | Treatment:tif-IA RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE014 | Treatment:tif-IA RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE023 | Treatment:tif-IA RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE032 | Treatment:tif-IA RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PE041 | Treatment:tif-IA RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG005 | Treatment:tif-IA RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG014 | Treatment:tif-IA RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG023 | Treatment:tif-IA RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG032 | Treatment:tif-IA RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PG041 | Treatment:tif-IA RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI005 | Treatment:tif-IA RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI014 | Treatment:tif-IA RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI023 | Treatment:tif-IA RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI032 | Treatment:tif-IA RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PI041 | Treatment:tif-IA RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS005 | Treatment:tif-IA RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS014 | Treatment:tif-IA RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS023 | Treatment:tif-IA RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS032 | Treatment:tif-IA RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_1_10_PS041 | Treatment:tif-IA RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC014 | Treatment:tif-IA RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC023 | Treatment:tif-IA RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC032 | Treatment:tif-IA RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phosphoPC041 | Treatment:tif-IA RNAi | Days of adulthood:6 | relative units |
Reversed phase NEGATIVE ION MODE | 191115_FW_1_project_Ermolaeva_phsophoPC005 | Treatment:tif-IA RNAi | Days of adulthood:6 | relative units |